Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Tamsulosin + Solifenacin, Atc G04Ca53 For The Period May 1St, 2023 - April 30Th, 2025

Name: Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Tamsulosin + Solifenacin, Atc G04Ca53 For The Period May 1St, 2023 - April 30Th, 2025
Start: 2023-03-18
End: 2025-03-05
Location: DAK-GESUNDHEIT

DAK-GESUNDHEIT Germany has Released a tender for Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Tamsulosin + Solifenacin, Atc G04Ca53 For The Period May 1St, 2023 - April 30Th, 2025 in Pharmaceuticals. The tender was released on Mar 18, 2023.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Tamsulosin + Solifenacin, Atc G04Ca53 For The Period May 1St, 2023 - April 30Th, 2025

Deadline - Mar 05, 2025

GT reference number - 63525382

Product classification - Pharmaceutical products

Organization Details:

Address - Germany

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 63525382

Document Type - Tender Notices

Notice Details and Documents:

Description - Invitation for Bids are invited for Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Ingredient Tamsulosin + Solifenacin, Atc G04Ca53 For The Period May 1St, 2023 - April 30Th, 2025. The Invitation fo r Bids has been released by DAK-GESUNDHEIT and the deadline is 2025-03-05. The notice is for Pharmaceutical products.

Gt Ref Id - 63525382

Deadline - Mar 05, 2025

View more tenders for

Pharmaceuticals Tenders Pharmaceutical products Tenders Germany Tenders

Similar Tenders :

Create Account

Join to access thousands of business opportunities

Quick Links

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database